TPO and Hashimoto thyroiditis: In an open controlled trial of 60 patients with chronic lymphocytic thyroiditis (59), the combination of L-T4+ Se possessed better efficacy than L-T4 monotherapy compared to the L-T4 group, TPO-Ab and TG-Ab were significantly reduced.